Amin, F. M., Linnet, T., Cullum, C. K., Do, T. P., & Younis, S. Tolerability of switch from erenumab to fremanezumab in adults with chronic migraine: A 3-month, single-center, prospective, real-world, observational study. BMC.
Chicago Style (17th ed.) CitationAmin, Faisal Mohammad, Thor Linnet, Christopher Kjaer Cullum, Thien Phu Do, and Samaira Younis. Tolerability of Switch from Erenumab to Fremanezumab in Adults with Chronic Migraine: A 3-month, Single-center, Prospective, Real-world, Observational Study. BMC.
MLA (9th ed.) CitationAmin, Faisal Mohammad, et al. Tolerability of Switch from Erenumab to Fremanezumab in Adults with Chronic Migraine: A 3-month, Single-center, Prospective, Real-world, Observational Study. BMC.
Warning: These citations may not always be 100% accurate.